Filtering by:

Salivary Gland Cancer
Top Story
November 28, 2018

FDA Approves Vitrakvi (Larotrectinib) for Tumors With Certain Genetic Change

For the second time, the US Food and Drug Administration (FDA) has approved a drug to treat tumors with a specific genetic change regardless of the type of cancer. Vitrakvi (larotrectinib) is for adults and children with solid tumors that test positive for NTRK genes, which can help cancerous tumors grow.

Cancer Updates, FDA, Genetics, Lung Cancer, Salivary Gland Cancer, Soft Tissue Sarcoma, Thyroid Cancer
March 22, 2016

ACS Releases Long-term Care Guideline for Survivors of Head and Neck Cancer

ACS Releases Long-term Care Guideline for Survivors of Head and Neck Cancer

Cancer Updates, Laryngeal and Hypopharyngeal Cancer, Nasal Cavity and Paranasal Sinus Cancer, Nasopharyngeal Cancer, Oral Cavity and Oropharyngeal Cancer, Salivary Gland Cancer, Survivorship
Latest News
Cancer Updates
Living Well
ACS Research
Stories of Hope
Special Coverage

Featured Topics

Breast CancerVaccinationsColon and Rectal Cancer

More Cancer News